Patent details
EP3266456 Title: COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER
Basic Information
- Publication number:
- EP3266456
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP171690985
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English Title of Invention:
- COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER
- French Title of Invention:
- COMBINAISONS CONTENANT DE L'IRINOTÉCAN LIPOSOMAL, DU 5-FU ET DU LEUCOVORIN DESTINÉES AU TRAITEMENT DU CANCER PANCRÉATIQUE
- German Title of Invention:
- ZUSAMMENSETZUNGEN AUS LIPOSOMALEM IRINOTECAN, 5-FU UND LEUCOVORIN ZUR BEHANDLUNG VON BAUCHSPEICHELDRÜSENKREBS
- SPC Number:
Dates
- Filing date:
- 12/06/2013
- Grant date:
- 05/05/2021
- EP Publication Date:
- 10/01/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/05/2021
- EP B1 Publication Date:
- 05/05/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/06/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/04/2021
- Name:
- Ipsen Biopharm Ltd.
- Address:
- Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 15/06/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- MOYO, Victor
- Address:
- United States (US)
2
- Name:
- FITZGERALD, Jonathan, Basil
- Address:
- United States (US)
3
- Name:
- LAIVINS, Peter
- Address:
- United States (US)
4
- Name:
- DHINDSA, Navreet
- Address:
- United States (US)
5
- Name:
- NIYIKIZA, Clet
- Address:
- United States (US)
6
- Name:
- KIM, Jaeyeon
- Address:
- United States (US)
7
- Name:
- BAYEVER, Eliel
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261659211 P
- Priority Date:
- 13/06/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201361784382 P
- Priority Date:
- 14/03/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4745; A61K 31/513; A61K 31/519; A61K 45/06; A61P 35/00; A61K 9/00; A61K 9/127; A61P 1/18; A61P 9/00; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202118
- Publication date:
- 05/05/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202211
- Publication date:
- 16/03/2022
- Description:
- Opposition procedure started
3
- Issue number:
- 202123
- Publication date:
- 09/06/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/06/2025
- Annual Fee Number:
- 13
- Annual Fee Amount:
- 180 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 27/05/2024
- Last Annual Fee Paid Number:
- 12
- Last Annual Fee Paid Amount:
- 165 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 15/06/2021 | Outgoing Correspondence | 1 |
| 14/06/2021 | Power Of Attorney | 1 |